Panion
  • Home
  • Emission
  • Our Story
    • History
    • Company
    • Management and Board
    • Advisory Board
    • Panion US
  • Science
    • Epilepsy in dogs
    • About Gene therapy
    • About NPY and AAV vectors
    • Patents and licences
  • Projects
    • Epilepsy
    • Other projects
  • News
    • Newsletter
  • Panion US
  • Investor relations
    • Emission
Select Page

The Board of Directors proposes that subsidiary is distributed to the shareholders

Feb 5, 2016

Read more >> (Only in swedish) Recent Posts Panion’s presentation at the investor meeting 14. December 2018 14 December, 2018 Panion starts clinical study in dogs 12 December, 2018 Invitation to investor meeting in Stockholm, Friday 14th of December 2018, 12-13 11...

Archives

  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • June 2016
  • May 2016
  • February 2016
  • August 2015
  • July 2015

Panion Animal Health AB

org. nr. 559018-4171

Anja E. H. Holm
+45 22 94 66 00
info@panion-animalhealth.com

Linked in

Twitter

Newsletter

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Read more